Benitec Biopharma
BNTC
BNTC
57 hedge funds and large institutions have $265M invested in Benitec Biopharma in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $290M → $265M (-$24.8M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $7K
Holders
57
Holding in Top 10
2
Calls
–
Puts
$7K
Top Buyers
| 1 | +$8.98M | |
| 2 | +$7.47M | |
| 3 | +$2.54M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.96M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.13M |
Top Sellers
| 1 | -$8.74M | |
| 2 | -$2.92M | |
| 3 | -$2.23M | |
| 4 |
Millennium Management
New York
|
-$417K |
| 5 |
LP
Longaeva Partners
Chicago,
Illinois
|
-$392K |